About BioCentriq
BioCentriq is a full service CDMO. We offer product development and clinical production for cell and gene therapies. BioCentriq was founded in 2019 and launched our pilot development plant at the same time. In October of 2020 we completed the validation of our GMP center and opened the doors for clinical manufacturing.
Our mission is to accelerate the advancement of cell and gene therapies by improving the efficiency and effectiveness of manufacturing processes and technologies. To support that mission, we also offer custom and standard workforce development programs to help close the skills gap that exists in the industry today.
Learn More
Want to learn more?
Request our full capabilities brochure!
Recent Updates
BioCentriq Acquired by GC for $73 Million
May 17, 2022Haro Hartounian, Ph.D. Honored by ROI-NJ in 2021 List of ROI Influencers for Health Care
October 25, 2021Terumo Blood and Cell Technologies is collaborating with BioCentriq to provide technologies and expertise to automate cell and gene therapy manufacturing
October 12, 2021NJII Launches New Digital Capability Center for Cell & Gene Therapy on Campus of NJIT
August 3, 2021Get In Touch
Please use the form below to get in touch with a member of our team.